These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33803438)

  • 21. Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization.
    Huen KH; Nik-Ahd F; Chen L; Lerman S; Singer J
    J Pediatr Urol; 2019 Apr; 15(2):178.e1-178.e7. PubMed ID: 30611650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.
    Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H
    J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro.
    Liu Y; Mi Z; Niu W; An X; Yuan X; Liu H; Wang Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Li P; Tong Y; Bai C
    Future Microbiol; 2016 Oct; 11():1383-1393. PubMed ID: 27538011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophages: a Panacea in Neuro-Urology?
    Leitner L; Kessler TM; Klumpp J
    Eur Urol Focus; 2020 May; 6(3):518-521. PubMed ID: 31732462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant
    Rathor N; Bahadur T; Thakur CK; Bamola VD; Das BK; Chaudhry R
    Indian J Med Res; 2023 Jun; 157(6):549-558. PubMed ID: 37530310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different Efflux Pump Systems in Acinetobacter baumannii and Their Role in Multidrug Resistance.
    Sharma S; Kaushik V; Kulshrestha M; Tiwari V
    Adv Exp Med Biol; 2023; 1370():155-168. PubMed ID: 36971967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage.
    Sisakhtpour B; Mirzaei A; Karbasizadeh V; Hosseini N; Shabani M; Moghim S
    Ann Clin Microbiol Antimicrob; 2022 Jan; 21(1):1. PubMed ID: 34996464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
    Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
    BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy.
    Rao S; Betancourt-Garcia M; Kare-Opaneye YO; Swierczewski BE; Bennett JW; Horne B; Fackler J; Suazo Hernandez LP; Brownstein MJ
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0082421. PubMed ID: 34662188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic urinary tract infections in patients with spinal cord lesions - biofilm infection with need for long-term antibiotic treatment.
    Tofte N; Nielsen AC; Trøstrup H; Andersen CB; Von Linstow M; Hansen B; Biering-Sørensen F; Høiby N; Moser C
    APMIS; 2017 Apr; 125(4):385-391. PubMed ID: 28407430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus for the treatment of upper urinary tract infections during pregnancy.
    Molina-Muñoz JS; Cuadrado-Angulo J; Grillo-Ardila CF; Angel-Müller E; Cortés JA; Leal-Castro AL; Vallejo-Ortega MT
    Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):37-52. PubMed ID: 37093937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.
    Vergadi E; Bitsori M; Maraki S; Galanakis E
    J Pediatr Urol; 2017 Oct; 13(5):495.e1-495.e6. PubMed ID: 28341427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term antibiotics for preventing recurrent urinary tract infection in children.
    Williams G; Craig JC
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001534. PubMed ID: 30932167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenemases: Transforming
    Ramirez MS; Bonomo RA; Tolmasky ME
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32384624
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigating Bacteriophages Targeting the Opportunistic Pathogen
    Styles KM; Thummeepak R; Leungtongkam U; Smith SE; Christie GS; Millard A; Moat J; Dowson CG; Wellington EMH; Sitthisak S; Sagona AP
    Antibiotics (Basel); 2020 Apr; 9(4):. PubMed ID: 32331271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
    Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
    Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.